Stocks Health care SHPH
NASDAQ · Health careShuttle Pharmaceuticals Holdings, Inc. (SHPH)
It posted a net loss of $10.3M. At June 30, 2026 it held $90.2K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 24, 2026.
Key facts about Shuttle Pharmaceuticals Holdings, Inc.
- Net worth
- Shuttle Pharmaceuticals Holdings, Inc. has a market value (market cap) of $5.5M at the latest share price, and shareholders' equity of $19.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $9.5M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on September 24, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Shuttle Pharmaceuticals Holdings, Inc.'s next report is expected around February 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Shuttle Pharmaceuticals Holdings, Inc. does
Shuttle Pharmaceuticals Holdings, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SHPH.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$11.7M | -$7.16 | n/a |
| 2024 | n/a | -$9.1M | -$82.60 | n/a |
| 2023 | n/a | -$6.6M | -$88.36 | -$5.6M |
| 2022 | n/a | -$5M | -$126.15 | n/a |
| 2022 | n/a | -$1.2M | -$52.20 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Shuttle Pharmaceuticals Holdings, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 24, 2026Quarterly report10-Q · period to June 30, 2026Shuttle Pharmaceuticals reported zero revenue, an ongoing net loss, and substantial doubt regarding its ability to continue as a going concern.Diluted EPS -$3.10 versus -$32.91.
- September 24, 2026Exhibits 8-K/A
- September 16, 2026
- September 11, 2026
- September 2, 2026Additional proxy material DEFA14A
- September 2, 2026Other event 8-K
- September 1, 2026
- August 28, 2026
- August 17, 2026Late quarterly report notice NT 10-Q
- August 17, 2026
Insider trades
What the people running Shuttle Pharmaceuticals Holdings, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| July 14, 2026 | Hrt Financial LP10% owner | Sold | 82,116 | $367.9K |
| July 13, 2026 | Hrt Financial LP10% owner | Sold | 1,033 | $4.8K |
| July 10, 2026 | Hrt Financial LP10% owner | Bought | 731 | $2.3K |
| July 9, 2026 | Hrt Financial LP10% owner | Bought | 8,266 | $27.9K |
| July 8, 2026 | Hrt Financial LP10% owner | Sold | 18,531 | $65.2K |
| July 7, 2026 | Hrt Financial LP10% owner | Sold | 10,580 | $35.2K |
| July 6, 2026 | Hrt Financial LP10% owner | Sold | 9,022 | $31.7K |
| July 2, 2026 | Hrt Financial LP10% owner | Bought | 7,851 | $27.8K |
Questions about SHPH
What does Shuttle Pharmaceuticals Holdings, Inc. do?
Shuttle Pharmaceuticals Holdings, Inc. is a company in the Health care sector, listed on NASDAQ as SHPH. Its shares trade on NASDAQ under the ticker SHPH.
What is Shuttle Pharmaceuticals Holdings, Inc.'s net worth?
Shuttle Pharmaceuticals Holdings, Inc. has a market value (market cap) of $5.5M at the latest share price, and shareholders' equity of $19.2M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Shuttle Pharmaceuticals Holdings, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $10.3M.
When did Shuttle Pharmaceuticals Holdings, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on September 24, 2026. It covers the period to June 30, 2026.
When is Shuttle Pharmaceuticals Holdings, Inc.'s next earnings report?
Shuttle Pharmaceuticals Holdings, Inc.'s next report is expected around February 3, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare SHPH with
Follow SHPH
Get an email when Shuttle Pharmaceuticals Holdings, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Shuttle Pharmaceuticals Holdings, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.